As a community pharmacist, patients will ask you more about Coenzyme Q10 for STATIN intolerance. Statin intolerance is present in about 9% of statin-treated patients, according to a recent meta-analysis. This finding is getting a lot of attention and is likely to increase interest in supplements that might help limit statin-induced muscle pain and weakness . Be prepa…
قراءة المزيدAs a clinical pharmacist, you should be familiar with the Role of statins in children. More children will be screened and treated for dyslipidemia, now that Canadian and american guidelines suggest expanded screening. About 1 in 300 children are born with familial hypercholesterolemia (FH), which can lead to heart disease , stroke , and early death in adulthood if n…
قراءة المزيدAs a pharmacist, you should know how to deal with statin muscle pain . Mounting evidence suggests that statin-associated muscle pain is driven by a patient’s expectation of harm. In fact, statin-intolerant patients often rate muscle symptoms similarly with statin OR placebo. But it’s still how they feel, often leading to poor adherence. Consider this approach for pat…
قراءة المزيدAs a nutrition pharmacy specialist, you will see more focus on diet and exercise for high triglycerides and less reliance on prescribed (Rx) medications. This is different from current practice... Fenofibrate ( Lipanthyl, Fenolip, etc) use is increasing, despite the fact that there's no proof it improves cardiovascular outcomes. Regu…
قراءة المزيدMany eligible adults with diabetes aren’t on a statin . We know that statins reduce cardiovascular (CV) risk in patients with type 1 or 2 diabetes , and guidelines recommend use. Plus statin use in patients with diabetes age 40 to 75 is a common quality measure. Follow these steps... Think of statins as "automatic" for most …
قراءة المزيدAs a hospital pharmacist, you will continue to see LESS use of non-statins (niacin, etc) for dyslipidemia due to limited evidence of CV benefit. Consider discontinuing non-statins when patients are admitted if there's no good reason for the patient to be on them. Use these tips to evaluate the need for non-statins... Save non-stati…
قراءة المزيدQuestions will come up about how to manage high triglycerides, due to recent guidance from the American College of Cardiology . We know that a fasting triglyceride level of 150 mg/dL or higher is a marker for cardiovascular (CV) disease. But using medications specifically to lower triglycerides isn’t proven to reduce CV events or to prevent pancreatitis, even in pati…
قراءة المزيدAs a pharmacist, you may know that up to 30% of statin patients get muscle pain, cramps, or weakness, usually in the larger muscles such as the thighs. You should suggest these strategies to help patients stay on the statin... Lowering the dose is often enough to reduce symptoms. Changing the statin to fluvastatin, pravastatin, or …
قراءة المزيدStatin INRERACTION alerts continue to cause confusion. We know to watch for the more problematic statins: simvastatin, lovastatin, or atorvastatin since they're metabolized by CYP3A4 the most. But be familiar with some of the less cut-and-dried interactions... Are all azole antifungals a big problem? No. Fl…
قراءة المزيدWhen should statins be used in adults under age 40? ― Statins clearly improve outcomes regardless of age in patients with a prior heart attack or stroke for SECONDARY prevention or in familial hypercholesterolemia with an LDL of 190 mg/dL or higher. But for others under 40, this is a gray area (there's no evidence). Don't jump …
قراءة المزيدFocus on statin dose statin dose instead of LDL levels. It's not about aiming for LDL goals anymore. The new thinking is that it's more important to get patients on a statin dose proven to lower cardiovascular risk than to get LDL to a certain number. Use these common scenarios when helping your patients... How should patients…
قراءة المزيدTherapeutic actions ㅡ HMG-CoA inhibitors are antihyperlipidemic. They are a fungal metabolite that inhibits the enzyme that catalyzes the first step in the cholesterol synthesis pathway in humans, resulting in a decrease in serum cholesterol and serum LDLs (associated with increased risk of CAD); either an increase or no change in serum HDLs (associated with decreas…
قراءة المزيدNPS | Notes in Pharmacy Specialties is a free, open-access, peer-reviewed site focused on pharmacy practice. Articles are immediately accessible, covering clinical pharmacy, pharmaceutical care, health promotion, informatics, and more.
Egypt - Phone: (+20)1210274589
Gmail: abdelwahabward@gmail.com
Social Plugin